Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003798579 | SCV004581949 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2024-05-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Met239Trpfs*19) in the CC2D2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CC2D2A are known to be pathogenic (PMID: 19777577). This variant is present in population databases (rs754985710, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with CC2D2A-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Juno Genomics, |
RCV004796846 | SCV005416019 | pathogenic | Meckel syndrome, type 6; Joubert syndrome 9; COACH syndrome 2; Retinitis pigmentosa 93 | criteria provided, single submitter | clinical testing | PVS1+PM2_Supporting+PP4 | |
Fulgent Genetics, |
RCV004796846 | SCV005660504 | likely pathogenic | Meckel syndrome, type 6; Joubert syndrome 9; COACH syndrome 2; Retinitis pigmentosa 93 | 2024-01-24 | criteria provided, single submitter | clinical testing |